Travere Therapeutics Correlations
TVTX Stock | USD 19.06 0.88 4.84% |
The current 90-days correlation between Travere Therapeutics and Dice Molecules Holdings is 0.06 (i.e., Significant diversification). The correlation of Travere Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Travere Therapeutics Correlation With Market
Modest diversification
The correlation between Travere Therapeutics and DJI is 0.2 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Travere Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Travere |
Moving together with Travere Stock
0.65 | KZR | Kezar Life Sciences | PairCorr |
0.61 | MLYS | Mineralys Therapeutics, | PairCorr |
0.71 | HPQ | HP Inc | PairCorr |
0.69 | BAC | Bank of America Aggressive Push | PairCorr |
0.84 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
0.77 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
Moving against Travere Stock
0.86 | VALN | Valneva SE ADR | PairCorr |
0.81 | MTEM | Molecular Templates | PairCorr |
0.8 | NKTX | Nkarta Inc | PairCorr |
0.8 | AGL | agilon health | PairCorr |
0.78 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.77 | CYRX | Cryoport | PairCorr |
0.76 | BACK | IMAC Holdings | PairCorr |
0.7 | IPSC | Century Therapeutics Buyout Trend | PairCorr |
0.68 | TPST | Tempest Therapeutics | PairCorr |
0.66 | ME | 23Andme Holding | PairCorr |
0.6 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
0.46 | TCHH | Trustcash Holdings | PairCorr |
0.42 | A | Agilent Technologies Sell-off Trend | PairCorr |
0.4 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.35 | MDWD | Mediwound | PairCorr |
0.91 | EC | Ecopetrol SA ADR | PairCorr |
0.8 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
0.68 | KO | Coca Cola Aggressive Push | PairCorr |
0.67 | SHG | Shinhan Financial | PairCorr |
0.61 | HYMTF | Hyundai Motor | PairCorr |
0.59 | VFSWW | VinFast Auto | PairCorr |
0.59 | TLK | Telkom Indonesia Tbk | PairCorr |
0.47 | WF | Woori Financial Group | PairCorr |
0.34 | PG | Procter Gamble | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Travere Stock performing well and Travere Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Travere Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
DICE | 2.09 | 0.72 | 0.30 | (0.94) | 1.14 | 5.66 | 37.64 | |||
CYTK | 1.89 | (0.39) | 0.00 | (0.10) | 0.00 | 3.42 | 14.08 | |||
VTYX | 3.06 | (0.36) | 0.00 | (0.03) | 0.00 | 6.94 | 16.88 | |||
COGT | 2.34 | (0.24) | 0.00 | (0.09) | 0.00 | 4.58 | 21.15 | |||
NUVL | 2.24 | 0.05 | 0.04 | 0.15 | 2.69 | 3.84 | 36.85 | |||
CERE | 0.77 | 0.07 | (0.04) | 1.31 | 0.94 | 1.91 | 6.40 | |||
GPCR | 2.96 | (0.25) | 0.00 | (0.23) | 0.00 | 8.18 | 24.50 | |||
RVMD | 2.00 | 0.31 | 0.13 | 0.39 | 2.04 | 4.81 | 10.95 | |||
AKRO | 2.37 | 0.03 | 0.05 | 0.14 | 2.82 | 5.23 | 13.37 | |||
RNA | 2.89 | (0.08) | 0.00 | 0.08 | 4.19 | 5.78 | 27.94 |
Travere Therapeutics Corporate Management
Elizabeth JD | General VP | Profile | |
Elizabeth Reed | General VP | Profile | |
William Rote | Senior Development | Profile | |
CFA CFA | Chief Officer | Profile | |
Angela Giannantonio | Senior Resources | Profile | |
Jula MD | Chief Officer | Profile | |
Casey Logan | Chief Officer | Profile |